Related references
Note: Only part of the references are listed.Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
Lesley A. Smith et al.
BMC CANCER (2010)
FoxM1 Mediates Resistance to Herceptin and Paclitaxel
Janai R. Carr et al.
CANCER RESEARCH (2010)
Homologous recombination in cancer development, treatment and development of drug resistance
Thomas Helleday
CARCINOGENESIS (2010)
A new target for proteasome inhibitors: FoxM1
Andrei L. Gartel
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Jimmy M. -M. Kwok et al.
MOLECULAR CANCER RESEARCH (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
Abhik Bandyopadhyay et al.
PLOS ONE (2010)
Triple negative breast cancers: Clinical and prognostic implications
S.J. Dawson et al.
EUROPEAN JOURNAL OF CANCER (2009)
Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications
S. Badve et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells
Masaaki Arai et al.
LIVER INTERNATIONAL (2009)
BRIT1/MCPH1 links chromatin remodelling to DNA damage response
Guang Peng et al.
NATURE CELL BIOLOGY (2009)
Triple-negative/basal-like breast cancer: review
Emad A. Rakha et al.
PATHOLOGY (2009)
The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics
Tracy A. Brooks et al.
NATURE REVIEWS CANCER (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Plk2 regulated centriole duplication is dependent on its localization to the centrioles and a functional polo-box domain
Onur Cizmecioglu et al.
CELL CYCLE (2008)
Apoptosis induced by replication inhibitors in Chk1-depleted cells is dependent upon the helicase cofactor Cdc45
R. Rodriguez et al.
CELL DEATH AND DIFFERENTIATION (2008)
DNA helicases Sgs1 and BLM promote DNA double-strand break resection
Serge Gravel et al.
GENES & DEVELOPMENT (2008)
RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin
Jing Mi et al.
MOLECULAR THERAPY (2008)
Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes
Yongjun Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Premal H. Thaker et al.
NATURE MEDICINE (2006)
Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers
DS Oh et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)
Shao-En Ong et al.
NATURE PROTOCOLS (2006)
Forkhead box m1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase
IC Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Molecular markers of prostate cancer outcome
DI Quinn et al.
EUROPEAN JOURNAL OF CANCER (2005)
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
C Nakanishi et al.
NATURE REVIEWS CANCER (2005)
SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing
J Li et al.
NEOPLASIA (2005)
Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor
VV Kalinichenko et al.
GENES & DEVELOPMENT (2004)
Transcription regulation and animal diversity
M Levine et al.
NATURE (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)